Emerging drugs for Duchenne muscular dystrophy
Author:
Publisher
Informa Healthcare
Subject
Pharmacology (medical),Pharmacology
Link
http://www.tandfonline.com/doi/pdf/10.1517/14728214.2012.691965
Reference133 articles.
1. Evidence-based path to newborn screening for duchenne muscular dystrophy
2. Clinical investigation in duchenne dystrophy: 2. Determination of the ?power? of therapeutic trials based on the natural history
3. Survival in Duchenne muscular dystrophy: improvements in life expectancy since 1967 and the impact of home nocturnal ventilation
4. Very mild muscular dystrophy associated with the deletion of 46% of dystrophin
Cited by 86 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Discovery of Quinazoline and Quinoline-Based Small Molecules as Utrophin Upregulators via AhR Antagonism for the Treatment of Duchenne Muscular Dystrophy;Journal of Medicinal Chemistry;2024-05-21
2. Evaluation of pro-regenerative and anti-inflammatory effects of isolecanoric acid in the muscle: Potential treatment of Duchenne Muscular Dystrophy;Biomedicine & Pharmacotherapy;2024-01
3. Long-Term Protective Effect of Human Dystrophin Expressing Chimeric (DEC) Cell Therapy on Amelioration of Function of Cardiac, Respiratory and Skeletal Muscles in Duchenne Muscular Dystrophy;Stem Cell Reviews and Reports;2022-05-19
4. Efficacy and Safety of Vamorolone in Duchenne Muscular Dystrophy;JAMA Network Open;2022-01-25
5. Resolvin-D2 targets myogenic cells and improves muscle regeneration in Duchenne muscular dystrophy;Nature Communications;2021-10-29
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3